High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback